A Multi-center, Randomized, Open-label, Phase IV Study to Investigate the Management of Pasireotide-induced Hyperglycemia With Incretin Based Therapy or Insulin in Adult Patients With Cushing's Disease or Acromegaly
Phase of Trial: Phase IV
Latest Information Update: 26 Jul 2018
At a glance
- Drugs Pasireotide (Primary) ; Insulin; Liraglutide; Metformin; Sitagliptin
- Indications Acromegaly; Pituitary ACTH hypersecretion
- Focus Therapeutic Use
- Sponsors Novartis Pharmaceuticals
- 31 Aug 2018 Biomarkers information updated
- 19 Jul 2018 Status changed from recruiting to completed.
- 25 Apr 2018 This trial has been completed in Belgium (End date: 2018-03-26).